Navigation Links
Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
Date:12/9/2010

"augments" protein levels in AAT deficient patients.   In the U.S. and Canada, PROLASTIN-C has replaced PROLASTIN, the leading augmentation therapy in North America for more than 20 years.  

Important Safety Information for PROLASTIN-C

The effect of augmentation therapy with any alpha(1)-proteinase inhibitor on pulmonary exacerbations and on the progression of emphysema in alpha(1)-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

PROLASTIN-C may contain trace amounts of IgA.  Patients with known antibodies to IgA, which can be present in patients with selective or severe IgA deficiency, have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions.  PROLASTIN-C is contraindicated in patients with antibodies against IgA.

The most common drug related adverse reactions during clinical trials in greater than or equal to 1% of subjects were chills, malaise, headache, rash, hot flush, and pruritus.  The most serious adverse reaction observed during the clinical studies with PROLASTIN-C was an abdominal and extremity rash in one subject.

PROLASTIN-C is made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, e.g., viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

In the US, for additional information on PROLASTIN-C, please see full prescribing information at www.PROLASTIN.com.  You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Alpha(1)-Antitrypsin Deficiency

Alpha(1)-antitrypsin deficiency, also known as AAT deficiency or Alpha-1, is an inherited disorder that causes significant reduction in the naturally occurring protein alpha(1)-proteina
'/>"/>

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
2. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
3. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
4. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
5. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
6. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
7. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
8. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
9. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
10. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
11. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that it will host a conference call ... results for the period ended March 31, 2015 and ... to its clinical program for aramchol. ...
(Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
(Date:5/6/2015)... 2015   Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... announced a $50,000 product donation to the Reproducibility ... key findings from recent high-impact papers in the field ... the online research marketplace Science Exchange , the ... open-access journal eLife. The goal of the ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... VR Laboratories LLC today announced the appointment ...  Rothman will head scientific research and development for ... market world-class botanical consumer, medicinal food and beverage, ... In addition to assisting in product development, Rothman ...
... 2011 Seven Summits Research issues critical PriceWatch Alerts for ... what our analysts have discovered about these stocks read the ... (Note: You may have to copy this link into your ... Alerts cover the following stocks: Barrick Gold Corporation (NYSE: ...
Cached Medicine Technology:James Rothman Named Chief Scientific Advisor at VR Laboratories 2James Rothman Named Chief Scientific Advisor at VR Laboratories 3James Rothman Named Chief Scientific Advisor at VR Laboratories 4Critical Alerts For Barrick Gold, Molycorp, Lockheed Martin, Teva Pharmaceutical, and Tenaris Released By Seven Summits Research 2
(Date:5/6/2015)... 2014 (PRWEB) May 06, 2015 ... on behalf of MEBC, an Alliance Award for ... Software during FOCUS 2015, JDA’s annual user conference ... manufacturing, retail and wholesale distribution sectors. This award ... clients are receiving services that advance their supply ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... 2015 Marketing Maven announces ... water, sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , ... world and it brings our agency great joy to ... Maven. “The ongoing relationship between WaterAid and ... to learn about and support the nonprofit as they ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Wolters ... healthcare professionals and students, announced today that in a ... confirmed that use of the clinical decision support resource ... the end of 2014, UpToDate users in more than ... topics per month, on average. In Germany alone, 95% ...
(Date:5/6/2015)... May 06, 2015 TU-Automotive has opened ... and autonomous vehicles make it to the headlines of ... Ford, Nissan, GM, Volvo and Hyundai ready to share ... this is the only way for press to go ... Charlotte Wright, marketing director, TU-Automotive said “This year we’re ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2
... Day, Rotary members around the globe are focused on the issue 24/7. , ... , , ... ... Rotary is committed to helping achieve the UN Millennium Development Goal that ...
... The film "Avatar" isn,t the only 3-D blockbuster making a ... unveiled a new technique for growing 3-D cell cultures, a ... millions of dollars in drug-testing costs. The research is reported ... easy enough for most labs to set up immediately. It ...
... New studies suggest promising new ways to ease atrial ... data presented at a major cardiology meeting Monday brought ... abnormal heartbeat that afflicts more than 2 million Americans. ... of the heart can quiver or race irregularly, rather ...
... that the Chilean government approved two of the company,s penem injectables. , ... , , ... ... ...
... emergency department can be avoided with effective palliative care, states ... ( CMAJ ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091187.pdf . In Ontario, ... the last 2 weeks of life. A study was ... cancer visit the emergency department near the end of life. ...
... is an accurate technique for locating and avoiding nerves ... Hospital researchers. The issue becomes important for ... continues to grow, so does the need for effective ... to avoid damage to them. Mechanomyography (MMG) systems ...
Cached Medicine News:Health News:Rotary Clubs Always Pumped for World Water Day 2Health News:Rotary Clubs Always Pumped for World Water Day 3Health News:3-D cell culture: Making cells feel right at home 2Health News:3-D cell culture: Making cells feel right at home 3Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 2Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 3Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 4Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 2Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 3Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 4Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 5Health News:Dying cancer patient visits to emergency departments can be avoided 2Health News:Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery 2
... Visionblue is a staining solution for ... required for performing a safe phaco-emulsification ... lens capsule may result in an ... risk of radial capsule tears and ...
Rhex-ID (Trypan Blue 0.8 mg)....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Auto refractometer....
Medicine Products: